Pulse Biosciences, Inc.
US ˙ NasdaqCM ˙ US74587B1017

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Maky Zanganeh. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Maky Zanganeh har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SMMT / Summit Therapeutics Inc. Co-Chief Executive Officer, Director, 10% Owner 556.093.090
US:PLSE / Pulse Biosciences, Inc. Director 725.395
US:PCYC / Pharmacyclics Chief Operating Officer 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Maky Zanganeh. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb PLSE / Pulse Biosciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PLSE / Pulse Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-06-23 PLSE Zanganeh Maky 1.193 10,7017 1.193 10,7017 12.767 230 44.2700 40.047 313,68
2020-06-17 PLSE Zanganeh Maky 7.950 7,0100 7.950 7,0100 55.730
2017-12-13 PLSE Zanganeh Maky 1.100 23,9800 1.100 23,9800 26.378
2017-12-12 PLSE Zanganeh Maky 1.000 23,9790 1.000 23,9790 23.979
2017-12-11 PLSE Zanganeh Maky 3.000 22,7630 3.000 22,7630 68.289
2017-09-18 PLSE Zanganeh Maky 7.775 15,0213 7.775 15,0213 116.791
2017-09-14 PLSE Zanganeh Maky 13.000 12,2263 13.000 12,2263 158.942
2017-09-14 PLSE Zanganeh Maky 9.000 13,5486 9.000 13,5486 121.937
2017-08-03 PLSE Zanganeh Maky 6.000 23,2270 6.000 23,2270 139.362
2017-08-03 PLSE Zanganeh Maky 9.500 23,8900 9.500 23,8900 226.955
2017-08-03 PLSE Zanganeh Maky 5.000 23,0030 5.000 23,0030 115.015
2017-08-02 PLSE Zanganeh Maky 8.290 25,1470 8.290 25,1470 208.469
2017-05-11 PLSE Zanganeh Maky 15.000 20,8360 15.000 20,8360 312.540
2017-05-10 PLSE Zanganeh Maky 5.000 21,7090 5.000 21,7090 108.545
2017-05-09 PLSE Zanganeh Maky 33.760 20,1570 33.760 20,1570 680.500
2017-03-20 PLSE Zanganeh Maky 5.000 22,4720 5.000 22,4720 112.360
2017-03-20 PLSE Zanganeh Maky 3.240 22,7080 3.240 22,7080 73.574
2017-03-20 PLSE Zanganeh Maky 1.040 23,7800 1.040 23,7800 24.731
2017-03-20 PLSE Zanganeh Maky 2.000 22,3700 2.000 22,3700 44.740
2017-03-20 PLSE Zanganeh Maky 1.000 22,3800 1.000 22,3800 22.380
2017-03-17 PLSE Zanganeh Maky 8.960 23,9960 8.960 23,9960 215.004
2017-03-17 PLSE Zanganeh Maky 2.000 23,9300 2.000 23,9300 47.860
2017-02-15 PLSE Zanganeh Maky 13.000 11,9730 13.000 11,9730 155.649
2017-02-15 PLSE Zanganeh Maky 6.200 12,1520 6.200 12,1520 75.342
2017-02-14 PLSE Zanganeh Maky 9.500 12,1190 9.500 12,1190 115.130
2017-02-13 PLSE Zanganeh Maky 2.000 11,2500 2.000 11,2500 22.500
2017-02-13 PLSE Zanganeh Maky 1.000 10,9660 1.000 10,9660 10.966

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PLSE / Pulse Biosciences, Inc. Insider Trades
Insidersalg PLSE / Pulse Biosciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PLSE / Pulse Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PLSE / Pulse Biosciences, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Maky Zanganeh som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-09-11 2025-09-11 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 5.000 556.093.090 0,00 18,07 90.350 10.048.602.136
2025-09-11 2025-09-10 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 333.394 556.088.090 0,06 17,68 5.894.406 9.831.637.431
2025-06-02 2025-05-30 4 SMMT Summit Therapeutics Inc.
Common Stock
M - Exercise 74.545 555.754.696 0,01 2,64 196.799 1.467.192.397
2025-04-09 2025-04-08 4 SMMT Summit Therapeutics Inc.
Common Stock
X - Other 3.985.055 555.680.151 0,72 1,58 6.296.387 877.974.639
2025-02-11 2025-02-03 4 PLSE PULSE BIOSCIENCES, INC.
Common Stock
X - Other 30.121 725.395 4,33 11,00 331.331 7.979.345
2025-02-11 2025-01-24 4 PLSE PULSE BIOSCIENCES, INC.
Common Stock
X - Other 30.121 695.274 4,53 11,00 331.331 7.648.014
2024-10-03 2024-10-03 4 SMMT Summit Therapeutics Inc.
Common Stock
X - Other 315.681 10.199.776 3,19 1,58 498.776 16.115.646
2024-09-13 2024-09-11 4 SMMT Summit Therapeutics Inc.
Common Stock
A - Award 44.052 24.967.852 0,18 22,70 999.980 566.770.240
2024-07-09 2024-07-03 4 PLSE PULSE BIOSCIENCES, INC.
Common Stock
X - Other 60.242 665.153 9,96
2024-03-27 2024-03-27 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 20.000 50.000 66,67 3,71 74.200 185.500
2024-03-27 2024-03-27 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 34.321 24.923.800 0,14 3,72 127.674 92.716.536
2024-03-27 2024-03-27 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 26.000 520.814 5,25 3,72 96.720 1.937.428
2024-03-27 2024-03-26 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 30.000 30.000 3,75 112.500 112.500
2023-12-13 2023-12-12 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 5.000 494.814 1,02 2,07 10.350 1.024.265
2023-12-13 2023-12-11 4 SMMT Summit Therapeutics Inc.
Common Stock
X - Other 315.681 24.889.479 1,28 1,58 498.776 39.325.377
2023-12-13 2023-12-11 4 SMMT Summit Therapeutics Inc.
Common Stock
X - Other 489.814 489.814 1,44 705.332 705.332
2023-11-15 2023-11-13 4 PLSE Pulse Biosciences, Inc.
Common Stock
M - Exercise 56.075 604.911 10,22 2,14 120.000 1.294.510
2023-11-15 2023-11-13 4 PLSE Pulse Biosciences, Inc.
Common Stock
M - Exercise 20.000 548.836 3,78 2,14 42.800 1.174.509
2023-07-06 2023-06-09 4/A PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 86.668 528.836 19,60 2,05 177.669 1.084.114
2023-06-13 2023-06-09 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 86.668 791.915 12,29 2,05 177.669 1.623.426
2023-03-13 2023-03-08 4/A SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 6.748.629 9.884.095 215,24 1,05 7.086.060 10.378.300
2023-03-13 2023-03-08 4/A SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 16.778.415 24.573.798 215,24 1,05 17.617.336 25.802.488
2023-03-08 2023-03-08 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 6.748.629 9.884.095 215,24 1,05 7.086.060 10.378.300
2023-03-08 2023-03-08 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 804.672 1.178.529 215,24 1,05 844.906 1.237.455
2023-03-08 2023-03-08 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 15.973.743 23.395.269 215,24 1,05 16.772.430 24.565.032
2022-12-09 2022-12-06 4 SMMT Summit Therapeutics Inc.
Common Stock
J - Other 373.857 10.930.849 3,54
2022-08-18 2022-08-16 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 1.030.925 3.135.466 48,99 0,97 999.997 3.041.402
2022-08-18 2022-08-16 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 4.593.777 7.061.557 186,15 0,97 4.455.964 6.849.710
2022-08-18 2022-08-16 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 184.430 359.969 105,06 0,97 178.897 349.170
2022-06-10 2022-06-09 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 86.668 442.168 24,38
2022-05-23 2022-05-19 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 56.075 56.075
2022-05-23 2022-05-19 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2021-12-17 2021-12-15 4 SMMT Summit Therapeutics Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2021-05-21 2021-05-20 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 8.026 8.026
2021-05-21 2021-05-20 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2021-05-14 2021-05-12 4 SMMT Summit Therapeutics Inc.
Common Stock
P - Purchase 389.077 2.643.319 17,26 5,24 2.038.763 13.850.992
2021-01-21 2021-01-19 4 PLSE Pulse Biosciences, Inc.
Warrant (right to buy)
X - Other -307 0 -100,00
2021-01-21 2021-01-19 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 307 107.074 0,29 7,01 2.152 750.589
2021-01-21 2021-01-08 4 PLSE Pulse Biosciences, Inc.
Warrant (right to buy)
X - Other -3.000 0 -100,00
2021-01-21 2021-01-08 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 3.000 355.500 0,85 7,01 21.030 2.492.055
2020-11-24 2020-11-22 4 SMMT Summit Therapeutics Inc.
Stock Option (right to buy)
A - Award 2.400.000 3.724.499 181,20
2020-11-13 2020-11-11 4 SMMT Summit Therapeutics Inc.
Stock Option (right to buy)
A - Award 3.323 1.324.500 0,25
2020-11-13 2020-11-11 4 SMMT Summit Therapeutics Inc.
Stock Option (right to buy)
A - Award 200.000 1.321.177 17,84
2020-11-13 3 SMMT Summit Therapeutics Inc.
Common Stock
2.254.242
2020-11-13 3 SMMT Summit Therapeutics Inc.
Common Stock
2.104.541
2020-06-25 2020-06-23 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1.193 106.767 1,13 10,70 12.767 1.142.588
2020-06-19 2020-06-17 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 7.950 105.574 8,14 7,01 55.730 740.074
2020-06-17 2020-06-15 4 PLSE Pulse Biosciences, Inc.
Warrant (right to buy)
P - Purchase 307 307
2020-06-17 2020-06-15 4 PLSE Pulse Biosciences, Inc.
Warrant (right to buy)
P - Purchase 3.000 3.000
2020-06-17 2020-06-15 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 2.050 97.624 2,14 7,01 14.370 684.344
2020-06-17 2020-06-15 4 PLSE Pulse Biosciences, Inc.
Common Stock
X - Other 20.000 352.500 6,02 7,01 140.200 2.471.025
2020-05-19 2020-05-18 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 14.071 14.071
2020-05-19 2020-05-18 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2019-05-17 2019-05-16 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 9.210 9.210
2019-05-17 2019-05-16 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2019-01-09 2019-01-07 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 2.364 2.364
2018-05-24 2018-05-23 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2018-03-28 3/A PLSE Pulse Biosciences, Inc.
Common Stock
11.500
2018-03-28 3/A PLSE Pulse Biosciences, Inc.
Common Stock
5.800
2018-03-28 2017-03-20 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1.000 14.000 7,69 22,38 22.380 313.320
2018-03-28 2017-03-20 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 2.000 27.000 8,00 22,37 44.740 603.990
2018-03-28 2017-03-17 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 2.000 25.000 8,70 23,93 47.860 598.250
2018-03-28 2017-02-15 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 6.200 13.000 91,18 12,15 75.342 157.976
2018-03-28 2017-02-14 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 9.500 23.000 70,37 12,12 115.130 278.737
2018-03-28 2017-02-13 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1.000 6.800 17,24 10,97 10.966 74.569
2018-03-28 2017-02-13 5 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 2.000 13.500 17,39 11,25 22.500 151.875
2017-12-15 2017-12-13 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1.100 95.574 1,16 23,98 26.378 2.291.865
2017-12-13 2017-12-12 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1.000 94.474 1,07 23,98 23.979 2.265.392
2017-12-13 2017-12-11 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 3.000 93.474 3,32 22,76 68.289 2.127.749
2017-11-06 2017-11-02 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2017-09-18 2017-09-18 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 7.775 332.500 2,39 15,02 116.791 4.994.582
2017-09-18 2017-09-14 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 9.000 324.725 2,85 13,55 121.937 4.399.569
2017-09-18 2017-09-14 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 13.000 315.725 4,29 12,23 158.942 3.860.149
2017-08-04 2017-08-03 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 5.000 90.474 5,85 23,00 115.015 2.081.173
2017-08-04 2017-08-03 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 9.500 302.725 3,24 23,89 226.955 7.232.100
2017-08-04 2017-08-03 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 6.000 293.225 2,09 23,23 139.362 6.810.737
2017-08-04 2017-08-02 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 8.290 287.225 2,97 25,15 208.469 7.222.847
2017-05-18 2017-05-16 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2017-05-11 2017-05-11 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 15.000 278.935 5,68 20,84 312.540 5.811.890
2017-05-11 2017-05-10 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 5.000 85.474 6,21 21,71 108.545 1.855.555
2017-05-11 2017-05-09 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 33.760 80.474 72,27 20,16 680.500 1.622.114
2017-03-20 2017-03-20 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 1.040 46.714 2,28 23,78 24.731 1.110.859
2017-03-20 2017-03-20 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 3.240 45.674 7,64 22,71 73.574 1.037.165
2017-03-20 2017-03-20 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 5.000 263.935 1,93 22,47 112.360 5.931.147
2017-03-20 2017-03-17 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 8.960 42.434 26,77 24,00 215.004 1.018.246
2017-02-22 2017-02-15 4 PLSE Pulse Biosciences, Inc.
Common Stock
P - Purchase 13.000 33.474 63,50 11,97 155.649 400.784
2017-02-13 2017-02-09 4 PLSE Pulse Biosciences, Inc.
Stock Option (right to buy)
A - Award 45.000 45.000
2017-02-13 3 PLSE Pulse Biosciences, Inc.
Common Stock
538.344
2017-02-13 3 PLSE Pulse Biosciences, Inc.
Common Stock
299.883
2017-02-13 3 PLSE Pulse Biosciences, Inc.
Common Stock
538.344
2017-02-13 3 PLSE Pulse Biosciences, Inc.
Common Stock
299.883
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock (Right to Buy)
D - Sale to Issuer -40.000 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock (Right to Buy)
D - Sale to Issuer -100.000 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock (Right to Buy)
D - Sale to Issuer -100.000 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock (Right to Buy)
D - Sale to Issuer -25.000 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -10.000 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -10.000 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -30.000 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -114.069 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -37.500 0 -100,00
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
U - Other -725 0 -100,00 261,25 -189.406
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
U - Other -900 0 -100,00 261,25 -235.125
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
U - Other -75.363 0 -100,00 261,25 -19.688.584
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
U - Other -351.293 0 -100,00 261,25 -91.775.296
2015-05-28 2015-05-26 4 PCYC PHARMACYCLICS INC
Common Stock
D - Sale to Issuer -15.000 351.293 -4,10 261,25 -3.918.750 91.775.296
2015-03-16 2015-03-12 4/A PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -92.500 37.500 -71,15
2015-03-16 2015-03-12 4/A PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -48.219 0 -100,00
2015-03-16 2015-03-12 4/A PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 48.219 366.031 15,17 2,30 110.904 841.871
2015-03-16 2015-03-12 4/A PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 92.500 317.812 41,05 0,75 69.375 238.359
2015-03-16 2015-03-11 4/A PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -30.000 114.069 -20,82
2015-03-16 2015-03-11 4/A PCYC PHARMACYCLICS INC
Common Stock
S - Sale -30.000 225.312 -11,75 254,11 -7.623.444 57.255.114
2015-03-16 2015-03-11 4/A PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 30.000 255.312 13,31 7,19 215.700 1.835.693
2015-03-13 2015-03-12 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -92.500 37.500 -71,15
2015-03-13 2015-03-12 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -48.219 0 -100,00
2015-03-13 2015-03-12 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise -48.219 366.031 -11,64 2,30 -110.904 841.871
2015-03-13 2015-03-12 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 92.500 317.812 41,05 0,75 69.375 238.359
2015-03-13 2015-03-11 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -30.000 114.069 -20,82
2015-03-13 2015-03-11 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -30.000 225.312 -11,75 254,11 -7.623.444 57.255.114
2015-03-13 2015-03-11 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 30.000 255.312 13,31 7,19 215.700 1.835.693
2015-01-21 2015-01-16 4 PCYC PHARMACYCLICS INC
Common Stock
A - Award 15.000 225.312 7,13
2014-11-12 2014-11-12 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -5.931 144.069 -3,95
2014-11-12 2014-11-12 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -658 210.312 -0,31 137,50 -90.475 28.917.900
2014-11-12 2014-11-12 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -5.273 210.970 -2,44 138,01 -727.741 29.116.539
2014-11-12 2014-11-12 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 5.931 216.243 2,82 7,19 42.644 1.554.787
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -23.000 48.219 -32,29
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -6.476 210.312 -2,99 133,88 -866.997 28.156.255
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -5.000 216.788 -2,25 133,76 -668.808 28.997.910
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -8.524 221.788 -3,70 133,94 -1.141.722 29.706.728
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -3.000 230.312 -1,29 133,50 -400.500 30.746.652
2014-11-12 2014-11-10 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 23.000 233.312 10,94 2,30 52.900 536.618
2014-11-12 2014-11-07 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -1.551 71.219 -2,13
2014-11-12 2014-11-07 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -1.551 210.312 -0,73 135,01 -209.401 28.394.223
2014-11-12 2014-11-07 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 1.551 211.863 0,74 2,30 3.567 487.285
2014-11-04 2014-10-31 4 PCYC PHARMACYCLICS INC
Common Stock
J - Other 1 210.312 0,00 80,93 81 17.020.235
2014-09-04 2014-09-04 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -5.000 72.770 -6,43
2014-09-04 2014-09-04 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -5.000 210.311 -2,32 122,00 -610.000 25.657.942
2014-09-04 2014-09-04 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 5.000 215.311 2,38 2,30 11.500 495.215
2014-09-04 2014-09-03 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
M - Exercise -7.000 77.770 -8,26
2014-09-04 2014-09-03 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -5.000 210.311 -2,32 121,10 -605.500 25.468.662
2014-09-04 2014-09-03 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -2.000 215.311 -0,92 122,74 -245.480 26.427.272
2014-09-04 2014-09-03 4 PCYC PHARMACYCLICS INC
Common Stock
M - Exercise 7.000 217.311 3,33 2,30 16.100 499.815
2014-05-01 2014-04-30 4 PCYC PHARMACYCLICS INC
Common Stock
J - Other 204 210.311 0,10 80,39 16.400 16.906.901
2014-04-04 2014-04-02 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
A - Award 40.000 40.000
2013-12-18 2013-12-16 4 PCYC PHARMACYCLICS INC
Common Stock
S - Sale -20.000 210.107 -8,69 107,55 -2.151.000 22.597.008
2013-05-01 2013-04-30 4 PCYC PHARMACYCLICS INC
Common Stock
J - Other 2.012 230.107 0,88 10,56 21.241 2.429.240
2012-10-29 2012-10-26 4 PCYC PHARMACYCLICS INC
Stock Option (Right to Buy)
A - Award 100.000 100.000
2012-05-02 2012-04-30 4 PCYC PHARMACYCLICS INC
Common Stock
J - Other 2.012 228.095 0,89 10,56 21.241 2.407.999
2010-12-15 3 PCYC PHARMACYCLICS INC
Common Stock
206.083
2010-12-15 3 PCYC PHARMACYCLICS INC
Common Stock
75.636
2010-12-15 3 PCYC PHARMACYCLICS INC
Common Stock
725
2010-12-15 3 PCYC PHARMACYCLICS INC
Common Stock
900
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)